The Cigna and Kaiser Permanente-backed mental healthcare app developer took its total funding to $220m in a round valuing it at about $1bn.
The Paypal and Citi-backed payment platform developer has secured an additional $90m following a $180m close in January.
Retinal disease drug developer Gyroscope Therapeutics has raised series C funding from investors including Fosun Pharma.
The solid tumour therapy developer secured $21.9m from investors including Dai-ichi Life, Binex, Bigen and Shibuya Kogyo.
The open-source software manager was valued above $800m in a round that included new corporate backer Salesforce Ventures.
Alphabet's CapitalG unit contributed to a series C round valuing the identity verification network provider at $1.5bn.
The Barclays-backed work management platform developer is looking to expand into new verticals after securing series B funding.
Trucking distribution system developer Baton raised $10.5m in a round co-led by Maersk Growth that included Prologis Ventures, Lineage Logistics and RyderVentures.
Chord has paid an undisclosed amount to purchase the customer data sofware provider, which had raised $7.2m from investors including Gradient Ventures last year.
Helsinn and Johnson & Johnson returned to add $21m in extra funding to the $44m series B round the surgical marker developer closed in 2018.
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
